Search
Results for 'clinic'
Clear-
Joining the Good Fight: Pennington Foundation Donates 15.5 Million Dollar Grant to Transform Cancer Care in Northern Nevada
Generous gift will establish the William N. Pennington Cancer Institute at Renown Health. The William N. Pennington Foundation has announced a $15.5 million gift to the Renown Health Foundation to help establish the William N. Pennington Cancer Institute at Renown. This gift will help to bolster care and clinical expertise to improve the lives of people with cancer across northern Nevada. This is the largest gift Renown has ever received. This is the second major donation Renown Health has received from The William N. Pennington Foundation. In 2016, the Pennington Foundation recognized the need for enhanced care and expertise for pediatrics and donated $7.5 million to Renown Children’s Hospital to establish the William N. Pennington Fund for Advanced Pediatric Care. Through this gift, 100,000 area children now have access to pediatric specialists and contemporary healthcare services at the region’s only children’s hospital. Prior to 2016, about 30 percent of all pediatric patients had to leave northern Nevada to receive the specialty care they needed. Now, thanks to the Pennington Foundation’s support, Renown estimates that 97% of all pediatric patients and their families can receive both general and specialty pediatric care locally. Now, improving access to cancer care services in northern Nevada is the priority. According to the National Cancer Institute, approximately 39.5% Americans will be diagnosed with cancer at some point during their lifetimes (based on 2015–2017 data). Here in Nevada, the American Cancer Society estimates 16,390 new cases of cancer will be diagnosed in 2022 and that 5,730 Nevadans will die from cancer this year. The most frequent cancers seen include breast, prostate, lung and colo-rectal cancers. “The Pennington Foundation gift is so appreciated, as it honors a man who had a passion for improving lives and provides a legacy for the our current generation,” said Thomas R. Graf, M.D., FAAFP, Chief Executive Officer of Renown Health. Dr Graf also serves as Chief Clinical and Quality Officer at Renown, and Senior Associate Dean for Clinical Affairs for University of Nevada, Reno School of Medicine. “We are deeply grateful for this transformative gift. This gift will allow Renown to continue our mission of making a genuine difference in the health and well-being of people with cancer- their families, and the communities we serve.” The Renown Institute for Cancer will now be named the William N. Pennington Cancer Institute in honor of the man who was a gaming pioneer, businessperson, and philanthropist. In former publications, the late philanthropist, Bill Pennington said, “During my many years in business, I was fortunate to work with thousands of wonderful employees, all of them Nevadans. Their efforts helped create the William N. Pennington Foundation, and I hope the Foundation will, in turn, help future generations of Nevadans for many years to come.” The Pennington grant will focus on bolstering expert clinical care to address the many concerns that come with a cancer diagnosis and allow people to stay in northern Nevada instead of having travel hundreds of miles out of the area for specialty care. The Institute will be devoted to advancing cancer care, cancer screening, prevention, and cancer research, including the ability to offer the latest clinical trials. “Our goal is to offer our community comprehensive clinical services, basic, translational and clinical research, medical education to students and post-graduate training, and population health with community outreach to reduce the burden of cancer. Ultimately, the vision is to become accredited by the National Cancer Institute,” said Max J. Coppes, MD, PhD, MBA, Cancer Center Director. “We are incredibly thankful and grateful for the commitment and support of the William N. Pennington Foundation,” said Greg Walaitis, Renown Health Foundation’s Chief Development Officer. “We appreciate the Pennington Foundation’s belief in Renown’s charitable mission to build a healthier community, together. We thank them for Joining the Good Fight.” Renown Health is the region’s largest locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health affiliated in June of 2021 to establish Nevada’s first integrated health system with missions in education, patient care, and clinical research. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.
-
William 'Bill' Plauth, MD, MMM, CPE Appointed Chief Medical Officer for Renown Health
Today, Renown Health announced the appointment of William “Bill” Plauth, MD, MMM, CPE as Chief Medical Officer for Renown Health, effective April 3, 2023. “I am excited to have Dr. Plauth join our team," said Brian Erling, MD, MBA, President & CEO of Renown Health. “Dr. Plauth is a distinguished physician with over 30 years of experience. Dr. Plauth’s extensive commitment to service is in alignment with our mission, vision, and values. He is a goal-oriented, collaborative executive who brings a depth of experience to Renown Health and to our community. He inspires others with his intelligence and proven abilities to engage others in advancing clinical quality and performance. I look forward to the strides our health system will make in helping people live better and healthier lives under his leadership.” In his role as Chief Medical Officer (CMO), Dr. Plauth will be responsible for continuous quality improvement, effective clinical resource management and serve as a liaison for organized medical staff activities. He will partner with nursing leadership to actively support performance improvement, risk management, and efficient resource utilization linked to evidence-based medicine. He will listen and foster a close relationship between and among physicians, management, and clinical staff. As CMO, Dr. Plauth will provide expertise, coordination, and leadership in support of elected medical staff leaders and partner with UNR Med leadership to ensure a positive training environment across Renown Health. “As a physician, I have always been humbled by the trust our patients and their families invest in all of us as a healthcare team,” says Bill Plauth, MD. “Over the years, to fulfill that trust, I have enjoyed engaging with my colleagues across clinical teams to adopt innovative approaches that respect those who do the work and to promote ease of practice. Such collaboration makes it possible for us to provide top-notch, compassionate care that addresses our patients' unique challenges and to improve their health and quality of life. At the end of the day, it is the people that make the difference.” Dr. Plauth adds, “I am delighted to join Renown Health, which as a not-for-profit, charitable health care organization has a long history of compassionate service. I look forward to working with my new medical, nursing, and administrative colleagues as we fulfill our mission of making a genuine difference in the health and wellbeing of the people and communities we serve.” Renown Health has more than 7,200 employees and serves Northern Nevada, Lake Tahoe, and Northeast California. The system includes Renown Regional Medical Center, Renown South Meadows Medical Center, Renown Rehabilitation Hospital and Renown Children’s Hospital. Renown also has over 50 medical group, urgent care, and outpatient imaging practices. Hometown Health is the insurance division of Renown Health and is northern Nevada’s largest local, not-for- profit health insurance company that provides wide-ranging medical coverage. Since 2014, Dr. Plauth has provided clinical leadership at Centura Health (CO), first serving as Chief Medical Officer at Mercy Regional Medical Center in Durango, CO, and then for the last four years as Chief Medical Officer for Centura Penrose & St. Francis Hospitals in Colorado Springs. He was responsible for clinical quality, high reliability patient safety initiatives, process improvement, pharmacy, care management, infection control and medical staff services. Formerly, Dr. Plauth served for fourteen years with CHRISTUS St. Vincent Regional Medical Center in Santa Fe, NM, first as a hospitalist and then with concurrent roles that included Chief of Staff; Medical Director, Clinical Informatics; Medical Director, Palliative Care and Acting Chief Medical Officer for Quality and Medical Staff Affairs. Board certified in both Internal Medicine and Hospice & Palliative Care, Dr. Plauth is a leader in quality improvement, patient safety and clinical informatics. He has also served as a medical director of a Long-Term Care and Skilled Nursing Center. Dr. Plauth received his Bachelor of Arts in Economics from the University of Virginia, Charlottesville, and his Medical Doctorate from Emory University in Atlanta with a sub-internship at Brigham and Women’s Hospital in Boston. He completed his internship and residency at University of California San Francisco, where he also served as Chief Resident. In the most recent U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada. No other hospital in Nevada earned recognition from U.S. News. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit www.renown.org/careers.
-
Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease
Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental and social data) started notifying consenting study participants who have certain genetic variants which predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease relevant to their underlying genetic condition. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Learn more at www.helix.com.
-
Paul Hauptman, MD, Named Dean of The University of Nevada, Reno School of Medicine and Chief Academic Officer for Renown Health
Paul J. Hauptman, MD, has been named Dean of The University of Nevada, Reno School of Medicine and Chief Academic Officer for Renown Health. Dr. Hauptman is a nationally recognized investigator in outcomes assessment in advanced heart failure, the evaluation of cardiac care delivery and clinical trials. Dr. Hauptman currently serves as Dean at the University of Tennessee Graduate School of Medicine-Knoxville and Chief Academic Officer at the University of Tennessee Medical Center. He begins his appointment on Oct. 17, 2022. The selection of Dr. Hauptman came following a nationwide search. “Dr. Hauptman has an impeccable background in all of the areas that we felt were essential in finding our new Dean,” University President Brian Sandoval said. “He has a passion for and a deep understanding of how we should be training Nevada’s next generation of physicians. He has vast experience in administering and delivering clinical programs that can have a profound impact on our local communities. He has incredible credentials in the research arena. He clearly articulated a compelling vision on how he hopes to magnify and grow the educational and research endeavors of our School of Medicine. Equally important, it was very clear that he felt that as we expand upon current educational and research initiatives to enhance our School of Medicine’s impact, he is committed to working collaboratively across the community in order to meet its greatest needs. On behalf of the entire University, we are excited to have Dr. Hauptman as our new dean. We want to offer Dr. Hauptman and his family a warm welcome to the Wolf Pack Family.” "The appointment of Dr. Paul Hauptman as dean is a great step forward for the Medical School and for Renown Health. His record of leadership, scholarship, scientific expertise and enthusiasm in building academic and clinical excellence, creates an even higher standard for medical education and quality health care in the next decade. In addition to his talent as a physician and professor, Paul brings a deep humanity and commitment to the study and practice of medicine. We are pleased to welcome Dr. Hauptman to Nevada and know he will do much to advance health and health care through world-class medical education, clinical research and patient care for our community and our state,” said Thomas R. Graf, MD, FAAFP, Chief Executive Officer of Renown Health. Dr Graf also serves as Chief Clinical and Quality Officer at Renown, and Senior Associate Dean for Clinical Affairs for University of Nevada, Reno School of Medicine. As Dean and Chief Academic Officer, Dr. Hauptman will support and advance the academic and clinical integration established under the affiliation between UNR Med and Renown Health. This affiliation benefits the community by recruiting top-tier physicians and health care professionals, improving access to and developing new models of innovative care, and investing in clinical research. As pillars of health care in northern Nevada, both organizations provide key services for underserved populations, and collaborate to educate, train and employ the next generation of doctors and health care professionals. Together, they support the health of local and rural communities, the state and the nation. “I am delighted to have this opportunity and honored to lead the School of Medicine and the academic mission of Renown Health for the betterment of our students, trainees, physicians, patients and community-at-large. This is a pivotal time for medical education and the delivery of quality healthcare, and I will be steadfast in ensuring student success and the growth of research that can meaningfully impact patients. I will do my best to build upon the legacy of Dr. Schwenk and look forward to collaborating with President Sandoval, Provost Thompson, and Dr. Graf and the Renown team. I am all in for the silver and blue – and purple!” A first-generation American and college graduate, Dr. Hauptman received his M.D. degree from Cornell University Medical College (now Weill Medical College) and completed his internal medicine training at Brigham and Women’s Hospital/Harvard Medical School in Boston and cardiology fellowships at both Mount Sinai Hospital (New York) and Brigham and Women’s. Dr. Hauptman was on faculty at Harvard Medical School and an attending physician in the Division of Cardiology at the Brigham (1993-1998) and subsequently served as Director of Heart Failure & Transplant and Assistant Dean of Clinical and Translational Research at Saint Louis University School of Medicine, where he held an adjunct position at the College for Public Health. .Program Advancing Access to Careers in Science Scholars fund, Disparities Awareness Month and the Women in ScienceHe has received research grants from the American Heart Association and National Institutes of Health and has served as a reviewer for the National Heart, Lung and Blood Institute and as a consultant to the Circulatory System Devices Panel and Medical Device Advisory Committee of the FDA. He also has extensive clinical trial experience as site Principal Investigator and an active member of steering, clinical events and data & safety monitoring committees. He previously worked as the part-time Medical Director of a medical device company (Biocontrol Medical, 2007-2011). After serving as Associate Editor at the European Journal of Heart Failure and Circulation: Heart Failure, he was Editor-in-Chief of the Journal of Cardiac Failure for six years (2015-2020). At the University of Tennessee, Dr. Hauptman has been deeply invested in the expansion of research capabilities, faculty development and health equity issues through initiatives such as the Academic Leadership Academy, a In recognition of his work as a mentor and patient advocate, Dr. Hauptman was named Teacher of the Year and received the Caring Physician Award from Saint Louis University. His major research interests have involved the assessment of outcomes in advanced heart failure, patient-physician communication and trends in cardiovascular care. He is the author of numerous abstracts, articles, book chapters, consensus guidelines and reviews. About UNR Med & Renown Health The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.
-
A Q&A with Dr. Brian Erling, CEO & President of Renown Health
On behalf of Renown’s more than 7,000 employees, we are thrilled to introduce our healthcare system’s next CEO and President, Brian Erling, MD, MBA. Dr. Erling joins Renown after working for more than 20 years in Colorado, most recently as the CEO and President of Penrose-St. Francis Health System in Colorado Springs for Centura Health. “I am so excited to join Renown Health at this important time. Healthcare and our economy are amid a major transformation, and Renown Health is very well positioned for the future,” Dr. Erling said. “Our ongoing success will hinge on our ability to establish positive and productive relationships, maintain high-quality patient clinical outcomes and experiences, reduce healthcare costs, encourage innovation and improve access and affordability for patients and members.” Q: Let’s start at the beginning. When did your interest in healthcare first begin? A: Believe it or not, I started my healthcare career during high school in Minnesota when I worked as a nursing assistant. I then worked as a monitor tech while pursuing my undergraduate degree in biology from Drake University in Des Moines, Iowa. Q: Where did you go to medical school, and what was your first job after training? A: After graduating from The John Hopkins University School of Medicine and spending three years at the University of Virginia for my residency, I spent more than a decade in the emergency department at a level 1 trauma center. Q: Does your experience as a physician impact your approach to healthcare leadership? A: Yes, absolutely. I have worked my fair share of nights, weekends and holidays, and I know the sacrifices healthcare workers – and their families – make to care for our communities. I will never take it for granted. I also understand how complex healthcare organizations are, and I have experienced these complexities from both the clinical and non-clinical sides. I have provided clinical leadership for a large, regional health system and understand that quality, safety and innovation come from the people doing the work, not from a corporate office. But you also need strong managers and leaders to facilitate and prioritize the work while providing support and coaching. Q: What is the key to a successful healthcare system? A: Teamwork. In fact, being part of a high-performing, mission-driven team is my number one motivation. It’s what gets me up in the morning and why I work in healthcare. I view our greatest resource to be our people, meaning Renown’s more than 7,000 employees. Modern technologies – such as fancy robots and imaging equipment – are essential and pretty cool, but they are not why our patients choose us. They come for trusted care in their hometown. Q: Renown Health is going through a lot of exciting changes right now. What is one thing that excites you about joining this healthcare system in a rapidly expanding area of the country? A: I am very excited about the new partnership with Renown and the University of Nevada, Reno School of Medicine. While still in its infancy, it provides the platform for us to be the center for training, research and tertiary care for the region and beyond. Q: What is something you have learned from working with CEOs at other healthcare systems? A: Healthcare leaders often have a short half-life, but that is not me. I believe it is difficult to create and move an organization toward a unified vision when your leader changes every few years. As my track record will support, this is not my style. I have been in Colorado for over twenty years and now look forward to making Reno and Renown my home for years to come. Q: As you know, Hometown Health is Renown’s health insurance arm. How does equitable access to insurance fit into a person’s and a community’s overall well-being? A: Most health systems would love to have their own health plan. The reality is that you cannot meaningfully improve the health of the population without managing value and risk. We are fortunate to have Hometown Health as part of Renown Health, and in our community, and I am excited to work with Bethany and the team to fulfill the mission of the organization. Q: What does working at a not-for-profit healthcare system mean to you? How does it differ from the for-profit sector? A: I have worked in for-profit and not-for-profit healthcare. Renown is unique as the only not-for-profit health system in the market. What that means is that we invest every penny earned back into caring for our community. We don’t send money to shareholders in California or Pennsylvania, we invest it right here in Nevada. Not only is a not-for-profit healthcare organization where I want to work for, but it is where my family and I want to go for care. Q: What do you like to do for fun? A: I love spending time with my wife and three adult children. I met my wife, Jessica, while attending medical school in Baltimore. She was working as a nurse in the surgical ICU, and I was smitten. I offered to help her with a 3 a.m. bed linen change and bath for our trauma patient, and the rest was history. I also love exploring the outdoors, especially snowboarding!
Read More About A Q&A with Dr. Brian Erling, CEO & President of Renown Health
-
The Healthy Nevada Project Changed My Life: A Local Mom's Story
Read about Jordan Stiteler, a local mom who says the Healthy Nevada Project provided insights into her family’s genetic makeup — and the likely cause of her dad and great grandfather’s deaths. Now she is changing her life due to her new diagnosis of familial hypercholesterolemia, which will allow her to take steps toward preventing the same fate. Jordan Stiteler’s dad died suddenly of a stroke nearly ten years ago — at only 45 years old. His grandfather died at age 40. Now through the Healthy Nevada Project’s no-cost genetic testing, she is closer to understanding why that may have happened. And she can take proactive steps to prevent the unhealthy symptoms that often lead to a stroke and heart problems. After getting her Geno 2.0 by National Geographic ancestry report, Stiteler got a call from Renown Institute for Heart & Vascular Health Cardiologist and Renown IHI Director of Research, Dr. Christopher Rowan. “They told me that I have FH, which is familial hypercholesterolemia,” she said. “I have genetically very high cholesterol because I have a non-functioning gene that doesn’t get rid of my cholesterol like a normal body would.” Familial Hypercholesterolemia: Simple Life Changes Dr. Rowan told Stiteler it is curable with medication and a change in lifestyle. Stiteler has embraced healthy lifestyle changes by exercising more and eating healthier. “It is so important. Being a mom, I think you have so much more to live for. Having this information has changed my life.” Stiteler feels confident FH affected her Dad. “It is helping my family realize that we need to get tested,” she said. “There were big milestones that my Dad missed. He didn’t get to see either of us get married or have our children. That was huge.” She has become passionate about sharing the need to join the Healthy Nevada Project as her way of helping to prevent other families from possibly going through what she and her family did with the early loss of her Dad. In addition to FH results, the Healthy Nevada Project is returning clinical results on BRCA 1/2 (hereditary breast and ovarian cancer) and Lynch syndrome (colorectal and endometrial cancer) to consenting study participants. To sign up for the Healthy Nevada Project, go to HealthyNV.org. Join the Healthy Nevada Project Recruitment for phase two is still open. In addition to opting in to receive clinical results, participants receive National Geographic’s Geno 2.0 ancestry app at no cost. They also have the chance to pick an additional app for health and wellness after completing a follow-up survey. Learn More or Sign Up
Read More About The Healthy Nevada Project Changed My Life: A Local Mom's Story
-
Department Spotlight: Pathology
Celebrate Leap Day by leaping into the world of Pathology at Renown Health! Think of discovering a diagnosis like solving a mystery: the condition is the suspect, the nurses are the frontline police force and the doctors are the lieutenants or captains finalizing the results of the case. You may notice that one crucial role is missing on this list – the detectives. In the diverse network of healthcare, the detectives are a significant part of each patient’s mystery-solving care team and represent many roles across our health system. When it comes to figuring out the elaborate details of a growth, disease, organ abnormality or cause of death, one team of detectives, quite literally, goes as deep as possible. Those detectives are the team members within Renown Pathology. For each specialized field within medicine or surgery, the Pathology department is here to play a crucial role in accurate diagnoses. With each slide examined and each test meticulously conducted in their bright laboratories, these dedicated professionals shape a path towards wellness and recovery. Meet Your Anatomy Experts Whether you have a chronic disease that needs consistent testing, a high-risk birth that requires placenta testing, a suspected cancerous tumor that needs a biopsy or a gall stone that must be removed (or anything in between), Renown’s Pathology team steps in to provide biological answers to your body’s questions. This department offers the most comprehensive in-house diagnostic testing in the region, from routine histology to full pathology. As the busiest pathology department in northern Nevada, this team boasts the fastest turnaround times from respected experts, including: Pathologists Pathology Assistants Histotechnicians Histotechnologists Clinical Lab Assistants Let’s break down the complex nature of these team members' jobs by walking through their everyday responsibilities at work! Pathologists Pathologists are medical doctors who specialize in the study and diagnosis of disease. With every slide they scrutinize and every sample they analyze, pathologists unravel the mysteries of disease with precision and compassion. Their responsibilities include interpreting laboratory tests, analyzing tissue and fluid samples (obtained from a variety of different sources, including biopsies and surgeries), staging cancer diagnoses and providing diagnostic insights that guide treatment decisions. “Our job is to help the patients and their doctors figure out what’s wrong,” said Dr. Christie Elliott, Pathologist and Medical Director of the Clinical Laboratory at Renown Regional Medical Center. “As the bulk of our cases deal with cancer, almost every day we start with a tumor board alongside fellow surgeons, oncologists, radiologists and geneticists. From there, we order extra studies, run through our cases to make diagnoses, review slides and ensure all information goes into the charts, which is especially important as 70% of data in medical charts is from the lab. A patient’s history is everything.” Pathology Assistants With the steadiest of hands, pathology assistants, also known as PAs (not to be confused with physician assistants), guide the diagnostic journey from patient specimen to diagnosis. They can typically be found processing surgical and biopsy specimens (includes accessioning, gross examination, description, and sampling for microscopic analysis), preparing tissue samples for microscopic evaluation, helping the pathologist determine a cause of death for autopsies by conducting organ dissections and maintaining detailed records of all diagnostic findings. “As a PA, I still impact patient care without being directly patient-facing,” said Andrew Whitner, Pathology Assistant. “I handle 300-350 small tissue blocks a day. During dissections, I identify landmarks, document what I see and turn those landmarks into slides, looking for things that don’t look normal.” “Our job is 90% all about gross specimens, and we also do eviscerations for autopsies,” added Leslieann Haffner, Pathology Assistant. “We are trained on what normal looks like; our goal is to find the abnormal.” Histotechnicians Histotechnicians work behind the scenes to help transform ordinary tissue into extraordinary windows of insight, revealing the inner workings of the human body. As vital members of the Pathology team, histotechnicians embed tissue specimens in paraffin wax blocks (a process that preserves the tissue's structure for examination), cut thin sections of tissue from the paraffin blocks using a microtome, mount tissue onto glass slides and stain the tissue slides using histological stains to highlight structures or cells. “With all the patient specimens we work with, we get to see a lot of organs and learn what is causing the abnormalities,” said Reiny Hitchcock, Histotechnician. “I enjoy the opportunities to expand my knowledge, especially while working alongside the doctors.” “Our job can change by the week,” added Jessica Fahrion, Histotechnician. “One week I’ll be in the grossing room, and the next week I might be training in cytology." Histotechnologists In a world where every slide holds the key to a patient's future, histotechnologists are the champions of progress. One career ladder step above histotechnicians, these team members often have a broader scope of responsibilities, including more complex laboratory procedures, developing and validating new techniques, managing laboratory operations, interpreting results and troubleshooting technical issues. You can count on histotechnologists for validating antibodies and handling orders from pathologists, oncologists, emergency physicians and more. “My day always involves looking into cases, reading reports, getting orders together and working with pathologists to help them with their diagnoses; I also work a lot with immunohistochemistry, helping out with routine slides,” said Charles Koeritz, Histotechnologist. “I especially enjoy doing validations, which help maintain the integrity of lab testing and our diagnostic processes.” Clinical Lab Assistants Our pathology clinical lab assistants are the masters at “filling in the blanks,” assisting in whatever area needs it most, especially in cytology and the grossing room. They are essential aspects of the Pathology team, collecting and storing specimens for further testing, assisting in managing test results, gathering data, managing supply inventory and more. “As a Clinical Lab Assistant, I can be scheduled anywhere, from tissue cassetting to grossing,” said Ellie Somers, Clinical Lab Assistant. “Working in cytology is one of my favorite parts of my job. It’s very rewarding to work with the doctors to uncover what treatments will help each patient. We do cytology very well here.” The Bottom Line Even though the Pathology department doesn’t always experience a lot of patient face-to-face time, they interact with patients in a different way – by uncovering the story that is the inner workings of the human body, one slide and one sample at a time. “It’s important to remember that the slide IS a patient,” said Dr. Elliott. “We are constantly learning from every case so we can continue to provide the best patient care possible.” Take a Photo Tour of the Pathology Lab!
-
Name-Brand Medication vs. Generic: What's the Difference?
Most prescriptions meds are available in generic form. Find out the similarities and differences between the two and how to determine whether a generic is right for you. Approximately 80 percent of prescriptions sold today are generics. If you’re taking a prescription medication, chances are it’s a generic form of the brand-name drug. But are you getting the same quality in a generic medication? Do generics measure up? The answer in most cases is yes — generics, just like branded products, are regulated by the Food and Drug Administration. “To have a generic product approved by the FDA, the generic manufacturer must prove that its product is bioequivalent to the branded product,” explains Adam Porath, PharmD, BCPS AQ-Cardiology, BCACP and Vice President of Pharmacy Services. Basically, it has to function the same. “Generic products are extremely well tolerated and will provide the same results as using a branded product,” Porath says. Here’s how generics are the same as name-brand prescriptions: Generic products contain the same active ingredients. They produce the same desired clinical effect and accompanying side effects. Generics come in the same form as their branded counterparts: pill, liquid or inhaler, for example. Release into the bloodstream matches the name brand in timing and strength. Here’s how they differ: Generics generally cost less. Federal law requires generics have different names and look different: shape, size, markings and color. Generics contain different inactive ingredients, like binders, fillers and artificial colors. Different side effects with generics can usually be attributed to these additions. Why do generics cost less? When pharmaceutical companies develop a new drug, they are paying for research, development, clinical studies, marketing — in some cases it can cost more than $800 million and take 10 to 15 years to develop a new drug. “The manufacturers of branded medication products have to recoup their research and development costs,” Porath says. So companies are granted a limited patent to sell their drug without the competition of generic counterparts. “When patent exclusivity ends, the market is open for any generic manufacturer to make a competing product with FDA approval.” Without the same startup costs, companies can sell generics at 80 to 85 percent less. And because more than one company can produce the same generics, competition drives prices even lower.
Read More About Name-Brand Medication vs. Generic: What's the Difference?
-
Cancer Care Team
Your Cancer Care Team Close to Home The William N. Pennington Cancer Institute team wants you to feel confident in the care we provide. Our dedicated doctors, nurses, therapists, dietitians, social workers, and other support staff work together to assure you receive the best care close to home. We serve our communities with the primary location in Reno, a satellite office at Carson Valley Health, and through Telehealth at Banner Churchill Community Hospital in Fallon, Nevada.